Global Cluster Headaches Market Size, Trends & Growth Opportunity, By Drug Type (Triptans, Octreotide, Opioids, and Others), By Drug Application (Abortive, Transitional, and Preventive), and By Product Type (Calcium Channel Blockers, Corticosteroids, Lithium Carbonate, Ergots, Melatonin, Anti-Seizure, and Local Anaesthetics), Regional Outlook, Competitive Market Share & Forecast, 2022 – 2027.
Global Cluster Headaches Market
Global Cluster Headaches Market was valued at USD 355.15 million in 2021 and is expected to reach USD 609.94 million by 2027, at a CAGR 5.57% from 2022-2027.
Cluster headache is a type of neurological disorder which is characterized by severe headaches recurring on one side of the head usually around the eye. This is accompanied by automatic symptoms such as excessive tears, swelling of the eye and nasal decongestion. In cluster headaches individuals often suffer from excruciating attacks of unilateral headaches.
Market Drivers
Growing aging population is one of the key driving factors which is expected to boost the global cluster headaches market growth. Furthermore, increasing technological advancements and developments in the healthcare industry will positively influence the market growth during the forecast period. 
Moreover, increase in television viewing and computer usage among the population is also expected to drive the market growth. Additionally, rising willingness among people to spend more on healthcare treatment is expected to fuel the market growth in near future.
Market Restraints
However, lack of awareness among healthcare providers is the major restraining factor which is expected hampers the global cluster headaches market growth. Also, unfavourable healthcare policies will obstruct the market growth. 
Market Segmentation
The Global Cluster Headaches Market is segmented into drug type such as Triptans, Octreotide, Opioids, and Others, by drug application such as Abortive, Transitional, and Preventive, by product type such as Calcium Channel Blockers, Corticosteroids, Lithium Carbonate, Ergots, Melatonin, Anti-Seizure, and Local Anaesthetics. 
Further, market is segmented into End user such as Hospitals, Clinics, Retail Pharmacies and Drug Stores, and E-commerce.
Regional Analysis
The Global Cluster Headaches Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North American region dominates the cluster headaches market due to the rise in the amount of diagnosis. Also, advanced technologies to diagnose cluster headaches will further boost the growth of the cluster headaches market in the region during the forecast period 2027. 
The Asia Pacific region is projected to have a significant amount of growth in the cluster headaches market due to the rise in the geriatric population.
Market Key Players
Various key players are discussed into the Global Cluster Headaches Market Report including: GlaxoSmithKline plc, Eli Lilly, and Company, Teva Pharmaceutical Industries Ltd., Novartis AG, AstraZeneca, Pfizer Inc., Fresenius Kabi, Sagent Pharmaceuticals, Inc., c, Aurobindo Pharma, and Others.
For instance, in June 2019, U.S Food and Drug Administration approved Eli Lilly’s – Emgality (galcanezumba-Gnlm) solution for injection for the treatment of episodic cluster headaches in adults.
Market Taxonomy
By Drug Type
•    Triptans
•    Octreotide
•    Opioids
•    Others
By Application
•    Abortive
•    Transitional
•    Preventive
By Product Types
•    Calcium Channel Blockers
•    Corticosteroids
•    Lithium Carbonate
•    Ergots
•    Melatonin
•    Anti-Seizure
•    Local Anaesthetics
By End user
•    Hospitals
•    Clinics
•    Retail Pharmacies and Drug Stores
•    E-commerce
By Region
•    North America
•    Latin America
•    Europe
•    Asia Pacific
•    Middle East & Africa

Global Cluster Headaches Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Cluster Headaches Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Cluster Headaches Market, By Drug Type
5.1 Y-o-Y Growth Comparison, By Drug Type 
5.2 Global Cluster Headaches Market Share Analysis, By Drug Type 
5.3 Global Cluster Headaches Market Size and Forecast, By Drug Type
5.3.1 Triptans
5.3.2 Octreotide
5.3.3 Opioids
5.3.4 Others
6 Global Cluster Headaches Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Cluster Headaches Market Share Analysis, By Application
6.3 Global Cluster Headaches Market Size and Forecast, By Application
6.3.1 Abortive
6.3.2 Transitional
6.3.3 Preventive
7 Global Cluster Headaches Market, By Product Type
7.1 Y-o-Y Growth Comparison, By Product Type
7.2 Global Cluster Headaches Market Share Analysis, By Product Type
7.3 Global Cluster Headaches Market Size and Forecast, By Product Type
7.3.1 Calcium Channel Blockers
7.3.2 Corticosteroids
7.3.3 Lithium Carbonate
7.3.4 Ergots
7.3.5 Melatonin
7.3.6 Anti- Seizure
7.3.7 Local Anaesthetics
8 Global Cluster Headaches Market, By End User
8.1 Y-o-Y Growth Comparison, By End User
8.2 Global Cluster Headaches Market Share Analysis, By End User
8.3 Global Cluster Headaches Market Size and Forecast, By End User
8.3.1 Hospitals
8.3.2 Clinics
8.3.3 Retail Pharmacies & Drug Stores
8.3.4 E-Commerce
9 Global Cluster Headaches Market, By Region
9.1 Global Cluster Headaches Market Share Analysis, By Region
9.2 Global Cluster Headaches Market Share Analysis, By Region
9.3 Global Cluster Headaches Market Size and Forecast, By Region
10 North America Cluster Headaches Analysis and Forecast (2022 – 2027)
10.1 Introduction
10.2 North America Cluster Headaches Market Share Analysis, By Drug Type
10.3 North America Cluster Headaches Market Size and Forecast, By Application
10.4 North America Cluster Headaches Market Size and Forecast, By Product Type
10.5 North America Cluster Headaches Market Size and Forecast, By End User
10.6 North America Cluster Headaches Market Size and Forecast, By Country
10.6.1 U.S.
10.6.2 Canada
10.6.3 Mexico
11 Europe Cluster Headaches Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Europe Cluster Headaches Market Share Analysis, By Drug Type 
11.3 Europe Cluster Headaches Market Size and Forecast, By Application 
11.4 Europe Cluster Headaches Market Size and Forecast, By Product Type
11.5 Europe Cluster Headaches Market Size and Forecast, By End User
11.6 Europe Cluster Headaches Market Size and Forecast, By Country
11.6.1 Germany
11.6.2 France
11.6.3 UK
11.6.4 Rest of Europe
12 Asia Pacific Cluster Headaches Market Analysis and Forecast (2022 – 2027)
12.1 Introduction
12.2 Asia Pacific Cluster Headaches Market Share Analysis, By Drug Type 
12.3 Asia Pacific Cluster Headaches Market Size and Forecast, By Application  
12.4 Asia Pacific Cluster Headaches Market Size and Forecast, By Product Type
12.5 Asia Pacific Cluster Headaches Market Size and Forecast, By End User
12.6 Asia Pacific Cluster Headaches Market Size and Forecast, By Country
12.6.1 China
12.6.2 Japan
12.6.3 India
12.6.4 Rest of Asia Pacific
13 Latin America Cluster Headaches Market Analysis and Forecast (2022 – 2027)
13.1 Introduction
13.2 Latin America Cluster Headaches Market Share Analysis, By Drug Type 
13.3 Latin America Cluster Headaches Market Size and Forecast, By Application 
13.4 Latin America Cluster Headaches Market Size and Forecast, By Product Type
13.5 Latin America Cluster Headaches Market Size and Forecast, By End User
13.6 Latin America Cluster Headaches Market Size and Forecast, By Country
13.6.1 Brazil
13.6.2 Rest of Latin America
14 Middle East Cluster Headaches Market Analysis and Forecast (2022 – 2027)
14.1 Introduction
14.2 Middle East Cluster Headaches Market Share Analysis, By Drug Type 
14.3 Middle East Cluster Headaches Market Size and Forecast, By Application 
14.4 Middle East Cluster Headaches Market Size and Forecast, By Product Type
14.5 Middle East Cluster Headaches Market Size and Forecast, By End User
14.6 Middle East Cluster Headaches Market Size and Forecast, By Country
14.6.1 Saudi Arabia
14.6.2 UAE
14.6.3 Egypt
14.6.4 Kuwait
14.6.5 South Africa
15 Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16 Company Profiles
16.1 GlaxoSmithKline plc
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 Eli Lilly and Company
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3 Teva Pharmaceutical Industries Ltd
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 Novartis AG
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 AstraZeneca
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 Pfizer Inc
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 Fresenius Kabi
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies 
16.8 Sagent Pharmaceuticals, Inc.
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies 
16.9 Aurobindo Pharma
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies 
16.10 Allergan plc
16.10.1 Overview
16.10.2 Offerings
16.10.3 Key Financials
16.10.4 Business Segment & Geographic Overview
16.10.5 Key Market Developments
16.10.6 Key Strategies